Julie A Johnson Selected Research

trandolapril (Mavik)

1/2019	Genome-wide association analysis of common genetic variants of resistant hypertension.
11/2015	PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
11/2014	Large-scale gene-centric analysis identifies polymorphisms for resistant hypertension.
10/2012	G protein receptor kinase 4 polymorphisms: β-blocker pharmacogenetics and treatment-related outcomes in hypertension.
8/2012	Comparing marginal structural models to standard methods for estimating treatment effects of antihypertensive combination therapy.
6/2011	Liver X receptor α gene polymorphisms and variable cardiovascular outcomes in patients treated with antihypertensive therapy: results from the INVEST-GENES study.
4/2011	Chromosome 9p21 haplotypes and prognosis in white and black patients with coronary artery disease.
1/2011	Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients.
12/2010	Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).
6/2007	Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie A Johnson Research Topics

Disease

54	Hypertension (High Blood Pressure) 01/2022 - 07/2003
13	Myocardial Infarction 01/2022 - 06/2007
12	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 06/2007
11	Stroke (Strokes) 01/2021 - 09/2007
11	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2002
10	Heart Failure 09/2011 - 10/2003
8	Essential Hypertension 03/2016 - 09/2010
5	Hyperglycemia 01/2018 - 10/2009
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 06/2011
4	Diabetes Mellitus 01/2022 - 10/2009
4	Hemorrhage 01/2022 - 09/2013
4	Neoplasms (Cancer) 01/2018 - 10/2009
3	Ischemic Stroke 01/2022 - 01/2017
3	Thrombosis (Thrombus) 01/2022 - 11/2020
3	Pain (Aches) 12/2021 - 01/2019
3	Inflammation (Inflammations) 01/2021 - 06/2011
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2015 - 01/2012
2	Chronic Renal Insufficiency 01/2022 - 01/2019
2	Unstable Angina 01/2022 - 01/2022
2	Chronic Pain 12/2021 - 01/2019
2	Gastroesophageal Reflux (GERD) 12/2021 - 01/2021
2	Infections 01/2021 - 01/2019
2	Atherosclerosis 01/2021 - 07/2017
2	Hypokalemia 01/2021 - 10/2009
2	Acute Coronary Syndrome 10/2020 - 04/2011
2	Invasive Fungal Infections 01/2017 - 07/2014
2	Chronic Disease (Chronic Diseases) 01/2013 - 06/2005
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2008 - 03/2008
2	Disease Susceptibility (Diathesis) 11/2006 - 10/2006
1	Esophagitis 01/2021
1	Postoperative Pain 01/2021
1	Hyperuricemia 01/2021
1	Duodenal Ulcer (Curling's Ulcer) 01/2021
1	Atherosclerotic Plaque (Atheroma) 11/2020
1	Rupture 11/2020
1	Albuminuria 01/2019
1	Kidney Diseases (Kidney Disease) 01/2019

Drug/Important Bio-Agent (IBA)

32	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 07/2003
18	Pharmaceutical PreparationsIBA 01/2022 - 12/2002
12	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2021 - 10/2009
12	Atenolol (Tenormin)FDA LinkGeneric 10/2016 - 01/2010
11	Verapamil (Calan)FDA LinkGeneric 01/2019 - 06/2007
10	trandolapril (Mavik)FDA LinkGeneric 01/2019 - 06/2007
8	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2022 - 07/2003
7	Cytochrome P-450 CYP2C19IBA 01/2022 - 07/2014
5	Biomarkers (Surrogate Marker)IBA 11/2019 - 06/2012
5	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 10/2009
4	Clopidogrel (Plavix)FDA Link 01/2022 - 05/2015
4	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2021 - 12/2004
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021 - 06/2007
4	DiureticsIBA 01/2021 - 08/2008
4	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2019 - 10/2009
3	Opioid Analgesics (Opioids)IBA 12/2021 - 01/2019
3	ThiazidesIBA 01/2021 - 10/2009
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 06/2007
3	ReninIBA 11/2019 - 01/2007
3	CholesterolIBA 01/2019 - 06/2011
3	Diltiazem (Cardizem)FDA LinkGeneric 06/2015 - 07/2013
3	beta Adrenergic ReceptorsIBA 05/2015 - 12/2002
3	Codon (Codons)IBA 04/2005 - 07/2003
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2017
2	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2016
2	Proton Pump InhibitorsIBA 12/2021 - 01/2021
2	Chlorthalidone (Chlortalidone)FDA LinkGeneric 01/2021 - 12/2017
2	PotassiumIBA 01/2021 - 10/2009
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021 - 07/2014
2	AcidsIBA 01/2021 - 04/2014
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2019
2	Voriconazole (Vfend)FDA LinkGeneric 01/2017 - 07/2014
2	Bisoprolol (Concor)FDA LinkGeneric 11/2015 - 05/2010
2	Amino Acids FDA Link 06/2015 - 04/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2015 - 04/2013
2	Adrenergic Agents (Adrenergic Drugs)IBA 05/2015 - 03/2008
2	EnzymesIBA 07/2014 - 12/2010
2	HDL LipoproteinsIBA 01/2013 - 01/2010
2	Carvedilol (Coreg)FDA LinkGeneric 12/2011 - 05/2010
2	Warfarin (Coumadin)FDA LinkGeneric 09/2011 - 03/2011
2	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2009 - 04/2008
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 01/2022
1	TabletsIBA 01/2022
1	Ondansetron (Zofran)FDA LinkGeneric 12/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2021
1	Opiate AlkaloidsIBA 12/2021
1	InflammasomesIBA 01/2021
1	IsoenzymesIBA 01/2021
1	Morphine (MS Contin)FDA LinkGeneric 01/2021
1	NLR ProteinsIBA 01/2021
1	factor V LeidenIBA 11/2020
1	Sorting NexinsIBA 01/2020
1	Dopamine D5 ReceptorsIBA 01/2020
1	CalcineurinIBA 11/2019
1	Inositol PhosphatesIBA 11/2019
1	Codeine (Codeine Phosphate)FDA LinkGeneric 01/2019
1	Angiotensin Receptor AntagonistsIBA 01/2019
1	Tramadol (K315)FDA LinkGeneric 01/2019

Therapy/Procedure

30	Therapeutics 01/2022 - 03/2005
3	Percutaneous Coronary Intervention 01/2022 - 05/2015
3	Secondary Prevention 01/2019 - 05/2015
2	Stents 01/2022 - 01/2022
2	Drug Therapy (Chemotherapy) 06/2011 - 08/2006